As interest in group psychedelic-assisted therapy grows, researchers are exploring diverse protocols, populations, and psychedelic medicines to enhance therapeutic outcomes and accessibility. This panel brings together experts conducting groundbreaking studies on group-based psychedelic therapy, offering insights into how different approaches can foster healing, connection, and transformation.
Chris Stauffer, Jae Sevelius, Anthony Back
Psychedelic-assisted therapy training programs are expanding, but the role of the psychedelic guide is still evolving. This presentation explores the qualities and influences shaping the modern psychedelic guide.
Valeria McCarroll
Speaker discusses underlying assumptions of psychedelic therapy and therapist's role, emphasizing presence in facilitating healing. Draws from personal experiences with MDMA, psilocybin, and ketamine research volunteers.
Norma Stevens
MDMA optimizes brain chemistry for safety, openness, and compassion. AEDP uses relational interventions to enhance MDMA's effects in trauma therapy, fostering trust, intimacy, and healing attachment.
Kari Gleiser
Study aims to re-examine inhaled cannabis for treating PTSD, with Phase 2 study assessing high THC cannabis versus placebo for managing symptoms and pain in 360 veterans across U.S.
Sue Sisley, Shane Pennington
Psilocybin service center facilitator discusses ceremonies and natural medicines in Colorado and Oregon's new state frameworks for participation in natural medicine practices.
William Wildcat Coakee, Sean McAllister, Dave Kopilak
Leaders of Oregon and Colorado campaigns discuss the historic creation of state frameworks for psychedelic healing, detailing the journey, current status, and future directions. Total words: 26
Kevin Matthews, Joshua Kappel
Psychedelic retreat centers are operating worldwide, with Oregon and Colorado preparing to regulate similar centers. These venues offer access to psychedelic experiences outside clinical settings, raising questions about their differences
Alexandra Pallas, Melissa Stangl, Ann “Annie Oak” Harrison
Integration of psychedelic therapy into healthcare requires clinics to provide safe care. Planning infrastructure carefully, considering environmental factors, is crucial for successful delivery of psychedelic services.
Daniel Kelly, Gregory Kearns, Payton Nyquvest
Psychedelic businesses have rapidly emerged on American and Canadian exchanges, creating a multibillion dollar market. Industry insiders discuss challenges and predictions for psychedelic public companies.
Patrick Trucchio, Florian Brand, George Tziras, Tim Chang
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.